Equities

Nuformix PLC

NFX:LSE

Nuformix PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.23
  • Today's Change-0.01 / -4.17%
  • Shares traded57.31m
  • 1 Year change212.29%
  • Beta2.4629
Data delayed at least 20 minutes, as of Feb 06 2026 16:00 GMT.
More ▼

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects Nuformix PLC share price to rise to 10.00 in the next year from the last price of 0.23.
High4,247.8%10.00
Med4,247.8%10.00
Low4,247.8%10.00

Earnings history & estimates

Nuformix PLC reported annual 2022 losses of -0.187 per share on Jul 28, 2022.
More ▼

Revenue history & estimates

Annual revenue information is not available for Nuformix plc.
Average growth rate-74.49%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.